StockData
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR) income statement

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$3.14−0.08 (-2.48%)

Close on Nov 20, 2026Market cap $326.19MP/E –Yield –

See a number that looks wrong?